Estefanía Cerro-Herreros

2PUBLICATIONS
11CO-AUTHORS
Clinical midwiferyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Feb 27, 2025
Use of HSALR female mice as a model for the study of myotonic dystrophy type I.

Marc Carrascosa-Sàez, Anna Colom-Rodrigo, Irene González-Martínez

|Oct 09, 2024
AntimiR treatment corrects myotonic dystrophy primary cell defects across several CTG repeat expansions with a dual mechanism of action.

Estefanía Cerro-Herreros, Judit Núñez-Manchón, Neia Naldaiz-Gastesi

Pageof 1

Frequent Collaborators

2 joint publications

Marc Carrascosa-Sàez

2 joint publications

Rubén Artero

1 joint publications

Neia Naldaiz-Gastesi

1 joint publications

Diego Piqueras Losilla

1 joint publications

Irene González-Martínez

1 joint publications

Jorge Espinosa-Espinosa

1 joint publications

Javier Poyatos-García

1 joint publications

Juan J Vilchez

1 joint publications

Mònica Suelves

1 joint publications

Gisela Nogales-Gadea

Frequent Collaborators

2 joint publications

Marc Carrascosa-Sàez

2 joint publications

Rubén Artero

1 joint publications

Neia Naldaiz-Gastesi

1 joint publications

Diego Piqueras Losilla

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)
11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)

Published on : May 10, 2016

12.1K
Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
09:39

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

Published on : Jul 29, 2016

15.3K
See more related videos

Top Related Videos

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)
11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)

Published on : May 10, 2016

12.1K
Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
09:39

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

Published on : Jul 29, 2016

15.3K
See more related videos